Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Logothetis

Showing results (891-900 of 1,104) with videos related to

Pageof 111
Sort By:
Nature Biotechnology|December 24, 2002
Fingerprinting the circulating repertoire of antibodies from cancer patientsPaul J Mintz, Jeri Kim, Kim-Anh Do, et al.
Journal of the National Cancer Institute|June 8, 2006
Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancerSun-Jin Kim, Hisanori Uehara, Sertac Yazici, et al.
Nature Communications|November 10, 2018
Systemic neurotransmitter responses to clinically approved and experimental neuropsychiatric drugsHamid R Noori, Lewis H Mervin, Vahid Bokharaie, et al.
Oncogene|February 18, 1999
Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancerB Czerniak, V Chaturvedi, L Li, et al.
Science Translational Medicine|August 3, 2018
Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the boneEleonora Dondossola, Stephanie Alexander, Boris M Holzapfel, et al.
Urology|January 1, 1992
Stage B (P2/3A/N0) transitional cell carcinoma of bladder highly curable by radical cystectomyK I Wishnow, A K Levinson, D E Johnson, et al.
Cancers|July 27, 2024
Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter MiceSong-Chang Lin, Guoyu Yu, Paul G Corn, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Discovery and horizontal follow-up of an autoantibody signature in human prostate cancerPaul J Mintz, Anna Cecilia Rietz, Marina Cardó-Vila, et al.
The Journal of Biological Chemistry|September 22, 2012
Distant cytosolic residues mediate a two-way molecular switch that controls the modulation of inwardly rectifying potassium (Kir) channels by cholesterol and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2))Avia Rosenhouse-Dantsker, Sergei Noskov, Huazhi Han, et al.
British Journal of Cancer|October 9, 2008
Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancerP Mathew, P F Thall, S Wen, et al.
Pageof 111

Showing results (891-900 of 1,104) with videos related to

Sort By:
Pageof 111
Nature Biotechnology|December 24, 2002
Fingerprinting the circulating repertoire of antibodies from cancer patientsPaul J Mintz, Jeri Kim, Kim-Anh Do, et al.
Journal of the National Cancer Institute|June 8, 2006
Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancerSun-Jin Kim, Hisanori Uehara, Sertac Yazici, et al.
Nature Communications|November 10, 2018
Systemic neurotransmitter responses to clinically approved and experimental neuropsychiatric drugsHamid R Noori, Lewis H Mervin, Vahid Bokharaie, et al.
Oncogene|February 18, 1999
Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancerB Czerniak, V Chaturvedi, L Li, et al.
Science Translational Medicine|August 3, 2018
Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the boneEleonora Dondossola, Stephanie Alexander, Boris M Holzapfel, et al.
Urology|January 1, 1992
Stage B (P2/3A/N0) transitional cell carcinoma of bladder highly curable by radical cystectomyK I Wishnow, A K Levinson, D E Johnson, et al.
Cancers|July 27, 2024
Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter MiceSong-Chang Lin, Guoyu Yu, Paul G Corn, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Discovery and horizontal follow-up of an autoantibody signature in human prostate cancerPaul J Mintz, Anna Cecilia Rietz, Marina Cardó-Vila, et al.
The Journal of Biological Chemistry|September 22, 2012
Distant cytosolic residues mediate a two-way molecular switch that controls the modulation of inwardly rectifying potassium (Kir) channels by cholesterol and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2))Avia Rosenhouse-Dantsker, Sergei Noskov, Huazhi Han, et al.
British Journal of Cancer|October 9, 2008
Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancerP Mathew, P F Thall, S Wen, et al.
Pageof 111